Investment Analysts’ updated eps estimates for Wednesday, September 30th:
3i Infrastructure (LON:3IN) had its hold rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Aldeyra Therapeutics (NASDAQ:ALDX) had its neutral rating reissued by analysts at HC Wainwright. The firm currently has a $2.00 price target on the stock.
Barksdale Resources (CVE:BRO) was upgraded by analysts at ATB Cormark Capital Markets from a sector perform rating to a speculative buy rating. They currently have C$0.30 target price on the stock, up from their previous target price of C$0.25.
Braze (NASDAQ:BRZE) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $38.00 target price on the stock.
BWX Technologies (NYSE:BWXT) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $235.00 target price on the stock.
BWX Technologies (NYSE:BWXT) had its buy rating reiterated by analysts at Guggenheim. They currently have a $192.00 price target on the stock.
Concentrix (NASDAQ:CNXC) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a $45.00 target price on the stock.
Dakota Gold (NYSE:DC) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $10.75 target price on the stock.
DocGo (NASDAQ:DCGO) had its buy rating reiterated by analysts at Needham & Company LLC.
Dyne Therapeutics (NASDAQ:DYN) had its buy rating reissued by analysts at Chardan Capital. They currently have a $38.00 target price on the stock.
Everplay Group (LON:EVPL) had its buy rating reaffirmed by analysts at Shore Capital Group Ltd. The firm currently has a GBX 470 price target on the stock.
Fair Isaac (NYSE:FICO) was downgraded by analysts at Bank of America Corporation from a buy rating to a neutral rating. They currently have $700.00 target price on the stock, down from their previous target price of $1,400.00.
Flywire (NASDAQ:FLYW) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $25.00 price target on the stock.
ForViva (LON:FVA) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 190 price target on the stock.
ForViva (LON:FVA) had its hold rating reiterated by analysts at Shore Capital Group Ltd. They currently have a GBX 135 target price on the stock.
Global Business Travel Group (NYSE:GBTG) had its neutral rating reaffirmed by analysts at BTIG Research.
Grocery Outlet (NASDAQ:GO) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. The firm currently has $15.00 target price on the stock, up from their previous target price of $12.50.
Greggs (LON:GRG) had its hold rating reiterated by analysts at Shore Capital Group Ltd. The firm currently has a GBX 1,910 target price on the stock.
John B. Sanfilippo & Son (NASDAQ:JBSS) had its buy rating reissued by analysts at BWS Financial. The firm currently has a $109.00 price target on the stock.
JD Sports Fashion (LON:JD) had its hold rating reissued by analysts at Shore Capital Group Ltd. They currently have a GBX 75 target price on the stock.
Jack Henry & Associates (NASDAQ:JKHY) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $178.00 target price on the stock.
CarMax (NYSE:KMX) had its underperform rating reissued by analysts at BNP Paribas Exane. They currently have a $48.00 price target on the stock, up from their previous price target of $33.00.
Kodal Minerals (LON:KOD) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 1.20 price target on the stock.
Levi Strauss & Co. (NYSE:LEVI) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $27.00 target price on the stock.
Lords Group Trading (LON:LORD) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 40 target price on the stock.
LyondellBasell Industries (NYSE:LYB) had its neutral rating reaffirmed by analysts at Citigroup Inc.. Citigroup Inc. currently has a $63.00 target price on the stock, down from their previous target price of $72.00.
Mobileye Global (NASDAQ:MBLY) had its equal weight rating reaffirmed by analysts at Barclays PLC. The firm currently has a $9.00 price target on the stock, down from their previous price target of $14.00.
MongoDB (NASDAQ:MDB) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $430.00 price target on the stock.
MongoDB (NASDAQ:MDB) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $465.00 target price on the stock.
MongoDB (NASDAQ:MDB) had its market outperform rating reissued by analysts at Citizens Jmp. They currently have a $519.00 target price on the stock.
Medtronic (NYSE:MDT) had its buy rating reaffirmed by analysts at TD Cowen. They currently have a $110.00 target price on the stock.
NiCE (NASDAQ:NICE) was upgraded by analysts at Oppenheimer Holdings, Inc. from a market perform rating to an outperform rating. They currently have $150.00 price target on the stock.
Procter & Gamble (NYSE:PG) had its hold rating reaffirmed by analysts at TD Cowen. TD Cowen currently has a $150.00 price target on the stock.
QumulusAI (NASDAQ:QMLS) had its buy rating reiterated by analysts at Chardan Capital. The firm currently has a $23.00 target price on the stock.
Arcus Biosciences (NYSE:RCUS) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $43.00 price target on the stock.
RHI Magnesita (LON:RHIM) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 4,000 target price on the stock.
Cartesian Therapeutics (NASDAQ:RNAC) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $25.00 target price on the stock.
Slate Grocery REIT (TSE:SGR.UN) was downgraded by analysts at ATB Cormark Capital Markets from an underperform rating to a tender rating. The firm currently has C$13.00 price target on the stock, up from their previous price target of C$8.00.
Slate Grocery REIT (TSE:SGR.UN) was downgraded by analysts at TD from a hold rating to a sell rating. The firm currently has C$13.00 price target on the stock, up from their previous price target of C$12.00.
Surgery Partners (NASDAQ:SGRY) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $19.00 price target on the stock.
Solstice Advanced Mat (NASDAQ:SOLS) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $82.00 price target on the stock.
Sangoma Technologies (TSE:STC) was downgraded by analysts at TD from a buy rating to a sell rating. The firm currently has C$7.35 target price on the stock, down from their previous target price of C$8.00.
Sangoma Technologies (TSE:STC) was downgraded by analysts at Acumen Capital from a buy rating to a tender rating. The firm currently has C$7.40 target price on the stock, down from their previous target price of C$11.00.
Sterling Infrastructure (NASDAQ:STRL) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $742.00 price target on the stock.
The Property Franchise Group (LON:TPFG) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 640 price target on the stock.
Uranium Energy (NYSEAMERICAN:UEC) had its buy rating reissued by analysts at HC Wainwright. They currently have a $26.75 target price on the stock.
Water Intelligence (LON:WATR) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 515 price target on the stock.
Yangarra Resources (TSE:YGR) was upgraded by analysts at ATB Cormark Capital Markets from a sector perform rating to an outperform rating. They currently have C$2.20 price target on the stock, up from their previous price target of C$1.80.
Zenas BioPharma (NASDAQ:ZBIO) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $44.00 price target on the stock.
Zenas BioPharma (NASDAQ:ZBIO) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $45.00 target price on the stock.
Receive News & Ratings for 3i Infrastructure plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3i Infrastructure plc and related companies with MarketBeat.com's FREE daily email newsletter.
